Impaired cardiac hypertrophic response in calcineurin Aβ-deficient mice

被引:207
作者
Bueno, OF
Wilkins, BJ
Tymitz, KM
Glascock, BJ
Kimball, TF
Lorenz, JN
Molkentin, JD [1 ]
机构
[1] Childrens Hosp, Med Ctr, Div Mol Cardiovasc Biol, Cincinnati, OH 45229 USA
[2] Childrens Hosp, Med Ctr, Div Cardiol, Dept Pediat, Cincinnati, OH 45229 USA
[3] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA
关键词
D O I
10.1073/pnas.072647999
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Calcineurin is a calcium- calmodulin-regulated, serine-threonine phosphatase that functions as a key inducer of stress responsive gene expression in multiple cell types through a direct activation of nuclear factor of activated T cells and myocyte enhancer factor 2 transcription factors. In cardiomyocytes, calcineurin signaling has been implicated in the regulation of the hypertrophic response caused by pressure overload or neuroendocrine stimulation. Three separate genes encode the catalytic subunit of calcineurin in mammalian cells, CnAalpha, CnAbeta, and CnAgamma. To evaluate the necessary function of calcineurin as a hypertrophic regulatory factor, the CnAbeta gene was disrupted in the mouse. CnAbeta-deficient mice were viable, fertile, and overtly normal well into adulthood, but displayed a 80% decrease in calcineurin enzymatic activity in the heart that was associated with a 12% reduction in basal heart size. CnAbeta-deficient mice were dramatically impaired in their ability to mount a productive hypertrophic response induced by pressure overload, angiotensin II infusion, or isoproterenol infusion. Analysis of marker genes associated with the hypertrophic response revealed a partial defect in the molecular program of hypertrophy. Collectively, these data solidify the hypothesis that calcineurin functions as a central regulator of the cardiac hypertrophic growth response in vivo.
引用
收藏
页码:4586 / 4591
页数:6
相关论文
共 31 条
  • [1] The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
    Bueno, OF
    De Windt, LJ
    Tymitz, KM
    Witt, SA
    Kimball, TR
    Klevitsky, R
    Hewett, TE
    Jones, SP
    Lefer, DJ
    Peng, CF
    Kitsis, RN
    Molkentin, JD
    [J]. EMBO JOURNAL, 2000, 19 (23) : 6341 - 6350
  • [2] Generic signals and specific outcomes:: Signaling through Ca2+, calcineurin, and NF-AT
    Crabtree, GR
    [J]. CELL, 1999, 96 (05) : 611 - 614
  • [3] Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart -: Cross-talk between cardiac hypertrophic signaling pathways
    De Windt, LJ
    Lim, HW
    Haq, S
    Force, T
    Molkentin, JD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (18) : 13571 - 13579
  • [4] Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo
    De Windt, LJ
    Lim, HW
    Bueno, OF
    Liang, QR
    Delling, U
    Braz, JC
    Glascock, BJ
    Kimball, TF
    del Monte, F
    Hajjar, RJ
    Molkentin, JD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (06) : 3322 - 3327
  • [5] Calcineurin inhibition ameliorates structural, contractile, and electrophysiologic consequences of postinfarction remodeling
    Deng, LL
    Huang, BY
    Qin, DY
    Ganguly, K
    El-Sherif, N
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2001, 12 (09) : 1055 - 1061
  • [6] Differential activation of transcription factors induced by Ca2+ response amplitude and duration
    Dolmetsch, RE
    Lewis, RS
    Goodnow, CC
    Healy, JI
    [J]. NATURE, 1997, 386 (6627) : 855 - 858
  • [7] An abnormal Ca2+ response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy
    Fatkin, D
    McConnell, BK
    Mudd, JO
    Semsarian, C
    Moskowitz, IGP
    Schoen, FJ
    Giewat, M
    Seidman, CE
    Seidman, JG
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (11) : 1351 - 1359
  • [8] DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways
    Fuentes, JJ
    Genescà, L
    Kingsbury, TJ
    Cunningham, KW
    Pérez-Riba, M
    Estivill, X
    de la Luna, S
    [J]. HUMAN MOLECULAR GENETICS, 2000, 9 (11) : 1681 - 1690
  • [9] Haq S, 2001, CIRCULATION, V103, P670
  • [10] Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension
    Ichihara, S
    Senbonmatsu, T
    Price, E
    Ichiki, T
    Gaffney, FA
    Inagami, T
    [J]. CIRCULATION, 2001, 104 (03) : 346 - 351